Hypercoagulation and hyperkinetic blood pressure indicative of physiological loss-of-control despite behavioural control in Africans: The SABPA study

References

• Roberts C, Troop N, Connan F, et al. The effects of stress on body weight: biological and psychological predictors of change in BMI. Obesity (Silver Spring, Md). 2007;15:3045–3055.
   PubMed Web of Science ®Google Scholar
• Rozanski A, Kubzansky LD. Psychologic functioning and physical health: a paradigm of flexibility. Psychosom Med. 2005;67(Suppl 1):S47–53.
   PubMed Web of Science ®Google Scholar
• Folkman S, Lazarus RS, Gruen RJ, DeLongis A. Appraisal, coping, health status, and psychological symptoms. J Pers Soc Psychol. 1986;50:571–579.
   PubMed Web of Science ®Google Scholar
• Malan L, Hamer M, Reimann M, et al. Defensive coping, urbanization, and neuroendocrine function in Black Africans: the THUSA study. Psychophysiology. 2012;49:807–814.
   PubMed Web of Science ®Google Scholar
• Malan L, Hamer M, Schlaich MP, et al. Facilitated defensive coping, silent ischaemia and ECG left-ventricular hypertrophy: the SABPA study. J Hypertens. 2012;30:543–550.
   PubMed Web of Science ®Google Scholar
• Malan L, Hamer M, Schlaich MP, et al. Defensive coping facilitates higher blood pressure and early sub-clinical structural vascular disease via alterations in heart rate variability: the SABPA study. Atherosclerosis. 2013;227:391–397.
   PubMed Web of Science ®Google Scholar
• Amirkhan JH. A factor analytically derived measure of coping: the Coping Strategy Indicator. J Pers Soc Psychol. 1990;59:1066–1074.
   Web of Science ®Google Scholar
• Light KC. Psychosocial precursors of hypertension: experimental evidence. Circulation. 1987;76:I67–176.
   Web of Science ®Google Scholar
• van Rhenen W, Schaufeli WB, van Dijk FJ, Blonk RW. Coping and sickness absence. Int Arch Occup Environ Health. 2008;81:461–472.
   PubMed Web of Science ®Google Scholar
• Garcia-Leon A, Reyes del Paso GA, Robles H, Vila J. Relative effects of harassment, frustration, and task characteristics on cardiovascular reactivity. Int J Psychophysiol. 2003;47:159–173.
   PubMed Web of Science ®Google Scholar
• Thomas KS, Nelesen RA, Ziegler MG, et al. Job strain, ethnicity, and sympathetic nervous system activity. Hypertension. 2004;44:891–896.
   PubMed Web of Science ®Google Scholar
• Malan L, Malan NT, Wissing MP, Seedat YK. Coping with urbanization: a cardiometabolic risk? The THUSA study. Biol Psychol. 2008;79:323–328.
   PubMed Web of Science ®Google Scholar
• de Kock A, Malan L, Hamer M, Malan NT. Defensive coping and subclinical vascular disease risk – associations with autonomic exhaustion in Africans and Caucasians: the SABPA study. Atherosclerosis. 2012;225:438–443.
   PubMed Web of Science ®Google Scholar
• Dimsdale JE. Psychological stress and cardiovascular disease. J Am Coll Cardiol. 2008;51:1237–1246.
   PubMed Web of Science ®Google Scholar
• Wirtz PH, Ehlert U, Emini L, et al. Anticipatory cognitive stress appraisal and the acute procoagulant stress response in men. Psychosom Med. 2006;68:851–858.
   PubMed Web of Science ®Google Scholar
• Bennett PC, Lane DA, Lip GY. Vital exhaustion and cardiovascular disease: are circulating fibrinogen and D-dimer levels a plausible link? Stress. 2008;11: 247–249.
   PubMed Web of Science ®Google Scholar
• Austin AW, Wissmann T, von Kanel R. Stress and hemostasis: an update. Semin Thromb Hemost. 2013;39:902–912.
   PubMed Web of Science ®Google Scholar
• Mausbach BT, Ancoli-Israel S, von Känel R, et al. Sleep disturbance, norepinephrine, and D-dimer are all related in elderly caregivers of people with Alzheimer disease. Sleep. 2006;29:1347–1352.
   PubMed Web of Science ®Google Scholar
• von Känel R, Dimsdale JE. Fibrin D-dimer: a marker of psychosocial distress and its implications for research in stress-related coronary artery disease. Clin Cardiol. 2003;26:164–168.
   PubMed Web of Science ®Google Scholar
• Zhou D, Yang PY, Zhou B, Rui YC. Fibrin D-dimer fragments enhance inflammatory responses in macrophages: role in advancing atherosclerosis. Clin Exp Pharmacol Physiol. 2007;34:185–190.
   PubMed Web of Science ®Google Scholar
• World Medical Association. Declaration of Helsinki. Ethical principles for medical research involving human subjects. J Indian Med Assoc. 2009;107:403–405.
   PubMedGoogle Scholar
• Kohara K, Nishida W, Maguchi M, Hiwada K. Autonomic nervous function in non-dipper essential hypertensive subjects. Evaluation by power spectral analysis of heart rate variability. Hypertension. 1995;26:808–814.
   PubMed Web of Science ®Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension. Blood Press. 2013;34:2159–2219.
   Google Scholar
• Hastedt M, Buchner M, Rothe M, et al. Detecting alcohol abuse: traditional blood alcohol markers compared to ethyl glucuronide (EtG) and fatty acid ethyl esters (FAEEs) measurement in hair. Forensic Sci Med Pathol. 2013;9:471–477.
   PubMed Web of Science ®Google Scholar
• Jarvis M, Tunstall-Pedoe H, Feyerabend C, et al. Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health. 1984;38:335–339.
   PubMed Web of Science ®Google Scholar
• Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317:1098.
   PubMed Web of Science ®Google Scholar
• Stein JH, Korcarz CE, Hurst RT, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography carotid intima–media thickness task force endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21:93–111.
   PubMed Web of Science ®Google Scholar
• Liang YL, Teede H, Kotsopoulos D, et al. Non-invasive measurements of arterial structure and function: repeatability, interrelationships and trial sample size. Clin Sci (Lond). 1998;95:669–679.
   PubMed Web of Science ®Google Scholar
• Roman MJ, Pickering TG, Schwartz JE, et al. Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults. J Am Coll Cardiol. 1996;28:751–756.
   PubMed Web of Science ®Google Scholar
• Hennerici MG, Bots ML, Ford I, et al. Rationale, design and population baseline characteristics of the PERFORM vascular project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) trial. Cardiovasc Drugs Ther. 2010;24:175–180.
   PubMed Web of Science ®Google Scholar
• Porter RS. (Ed). The Merck manual of diagnosis and therapy, 19th ed. Merck Research Laboratories, Whitehouse Station, NJ: Wiley; 2011.
   Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate – a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57:289–300.
   Google Scholar
• Kamath S, Lip GY. Fibrinogen: biochemistry, epidemiology and determinants. QJM. 2003;96:711–729.
   PubMed Web of Science ®Google Scholar
• Baldassarre D, De Jong A, Amato M, et al. Carotid intima–media thickness and markers of inflammation, endothelial damage and hemostasis. Ann Med. 2008;40:21–44.
   PubMed Web of Science ®Google Scholar
• Touboul PJ, Labreuche J, Vicaut E, et al. Country-based reference values and impact of cardiovascular risk factors on carotid intima–media thickness in a French population: the “Paroi Arterielle et Risque Cardio-Vasculaire” (PARC) study. Cerebrovasc Dis. 2009;27:361–367.
   PubMed Web of Science ®Google Scholar
• von Känel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol. 2000;65:357–369.
   PubMed Web of Science ®Google Scholar
• Preckel D, von Känel R. Regulation of hemostasis by the sympathetic nervous system: any contribution to coronary artery disease? Heart Drug. 2004;4:123–130.
   Google Scholar
• Schlaich MP, Kaye DM, Lambert E, et al. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation. 2003;108:560–565.
   PubMed Web of Science ®Google Scholar
• Hamer M, Malan L. Psychophysiological risk markers of cardiovascular disease. Neurosci Biobehav Rev. 2010;35:76–83.
   PubMed Web of Science ®Google Scholar
• McEwen BS. Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol. 2008;583:174–185.
   PubMed Web of Science ®Google Scholar
• Diehl M, Coyle N, Labouvie-Vief G. Age and sex differences in strategies of coping and defense across the life span. Psychol Aging. 1996;11:127–139.
   PubMed Web of Science ®Google Scholar
• Frydenberg E, Lewis R. Teaching coping to adolescents: when and to whom? Am Educ Res J. 2000;37:727–745.
   Web of Science ®Google Scholar